Former Chief Medical Officer · REGENXBIO Inc. (RGNX)

Stephen Yoo

A named executive officer of REGENXBIO in every fiscal year CompBrief holds from FY2016 to FY2018. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$1,884,032

Salary $397,900Stock awards $0

FY2017: $1,077,322

4th of 5 named executive officers at Regenxbio by FY2018 total.

5 named officers on file for REGENXBIO, FY2018

Stephen Yoo’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing
  • RGNX’s disclosed peer group of 15 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how REGENXBIO’s whole pay program stands against its peers

  • REGENXBIO’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on RGNX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 11, 2019 (DEF 14A).

Free

Get Stephen Yoo’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Stephen Yoo compensation by year

REGENXBIO Summary Compensation Table · all 3 fiscal years held
In US dollars, as REGENXBIO reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018
Salary$374,920$386,250$397,900
Bonus$0$0$0
Stock awards$0$0$0
Option awards$615,817$533,600$1,310,319
Non-equity incentive$103,359$141,947$160,000
Pension and deferred compensation$0$0$0
All other$17,513$15,525$15,813
Total$1,111,609$1,077,322$1,884,032

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: REGENXBIO Inc. DEF 14A filed April 11, 2019, accession 0001193125-19-103878, and prior-year filings. Open the filing on EDGAR.

How this page was built: the REGENXBIO Inc. filed document, accession 0001193125-19-103878. Every figure is read from that document and cited to the page and table it appears in. Filed April 11, 2019.

$1.1M
$1.1M
$1.9M
FY16
FY17
FY18
SalaryNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2018 year-end
TypeUnvested unitsValue at year-endExercise price
Option7,292—$3.76
Option18,958—$13.09
Option20,833—$19.50
Option55,000—$35.80

Per the Outstanding Equity Awards at Fiscal Year-End table in REGENXBIO Inc.'s FY2018 proxy; value at the fiscal year-end close, as the company printed it.

REGENXBIO’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
Kenneth MillsPresident and CEO$4,938,199
Vittal VasistaChief Financial Officer$1,944,391
Curran SimpsonSenior Vice President, Chief Operations and Technology Officer$1,901,142
Stephen Yoo · this pageFormer Chief Medical Officer$1,884,032
Olivier DanosChief Scientific Officer$1,613,769

The full REGENXBIO compensation record

free company brief

This page is one person within REGENXBIO's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are REGENXBIO's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Stephen Yoo's compensation dossier · One-time report. No refunds.